Today's News |
|
Vancouver-based A.I. Drug Discovery Platform Developer AbCellera Raises Range to $17 to $18 ahead of $403 Million IPO
Friday, December 11, 2020
Vancouver, BC, December 11, 2020--AbCellera Biologics, which provides an AI powered drug discovery platform for antibody therapies, raised the proposed deal size for its upcoming IPO on Thursday. The Vancouver, Canada-based company now plans to raise $403 million by offering 23 million shares at a price range of $17 to $18. The company had previously filed to offer the same number of shares at a range of $14 to $17. At the midpoint of the revised range, AbCellera Biologics will raise 13% more in proceeds than previously anticipated.
|
Share |
|||
|
Member Toolbar |
Renaissance Capital Posted: Dec 11, 2020 |
News Actions |
Navigation |
Hiring Today |
|||||||||||||||||||
See All Jobs |
|||||||||||||||||||
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
|